CARDINAL HEALTH 108, LLC - *EMERGENCY* MARIBAVIR LIVTENCITY 200MG TABLETS (#56 TABLETS/BOTTLES), QTY. 2 FOR THE BROOKLYN, NY CAMPUS .
Key Details
Description
*EMERGENCY* MARIBAVIR LIVTENCITY 200MG TABLETS (#56 TABLETS/BOTTLES), QTY. 2 FOR THE BROOKLYN, NY CAMPUS .
Context & Analysis
On Nov 7, 2025, Department of Veterans Affairs obligated $18,757.44 to CARDINAL HEALTH 108, LLC for *emergency* maribavir livtencity 200mg tablets (#56 tablets/bottles), qty. 2 for the brooklyn, ny campus .. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: not competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in DUBLIN, OH. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.